Clinical Trials Browser

Terminated × Lung Neoplasms × Tinzaparin × Clear all

NCT03090880 2022-11-17

PROVE

Phase 3 Terminated

Classical hematologyThoracic

Lung Neoplasms, Venous Thromboembolism